PubRank

Incidence of Diabetes and Cardiovascular Disease in Mexican Americans

Clinical Trial ID NCT00005205

PubWeight™ 40.56‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00005205

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001 5.87
2 The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003 5.27
3 Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 2002 5.10
4 Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990 3.95
5 Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes Care 2004 3.51
6 Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992 3.27
7 National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 2004 2.65
8 Waist circumference as the best predictor of noninsulin dependent diabetes mellitus (NIDDM) compared to body mass index, waist/hip ratio and other anthropometric measurements in Mexican Americans--a 7-year prospective study. Obes Res 1997 2.63
9 All-cause and cardiovascular mortality among Mexican-American and non-Hispanic White older participants in the San Antonio Heart Study- evidence against the "Hispanic paradox". Am J Epidemiol 2003 2.53
10 Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003 2.29
11 All-cause and cardiovascular mortality among diabetic participants in the San Antonio Heart Study: evidence against the "Hispanic Paradox". Diabetes Care 2002 2.22
12 Prediction of type 2 diabetes using simple measures of insulin resistance: combined results from the San Antonio Heart Study, the Mexico City Diabetes Study, and the Insulin Resistance Atherosclerosis Study. Diabetes 2003 2.22
13 Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 1990 2.15
14 Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes 1995 2.09
15 Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001 1.88
16 Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: implications for preventing coronary heart disease during the prediabetic state. Circulation 2000 1.78
17 Serum leptin levels in Mexican Americans and non-Hispanic whites: association with body mass index and cigarette smoking. Ann Epidemiol 1997 1.56
18 Clinical gallbladder disease in NIDDM subjects. Relationship to duration of diabetes and severity of glycemia. Diabetes Care 1993 1.56
19 Mode of onset of type 2 diabetes from normal or impaired glucose tolerance. Diabetes 2004 1.53
20 Do Mexican Americans really have low rates of cardiovascular disease? Prev Med 1999 1.47
21 Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care 1991 1.45
22 Metabolic precursors of hypertension. The San Antonio Heart Study. Arch Intern Med 1996 1.36
23 A population perspective on diabetes prevention: whom should we target for preventing weight gain? Diabetes Care 2003 1.33
24 Migration status, socioeconomic status, and mortality rates in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Ann Epidemiol 1996 1.28
25 Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension 1992 1.27
26 Obesity in Mexican American subgroups: findings from the San Antonio Heart Study. Am J Clin Nutr 1991 1.26
27 Low fasting plasma glucose level as a predictor of cardiovascular disease and all-cause mortality. Circulation 2000 1.24
28 Eight-year incidence of hypertension in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Am J Hypertens 1992 1.23
29 Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects? Arteriosclerosis 1990 1.19
30 Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 1996 1.15
31 Effects of cigarette smoking, diabetes, high cholesterol, and hypertension on all-cause mortality and cardiovascular disease mortality in Mexican Americans. The San Antonio Heart Study. Am J Epidemiol 1996 1.15
32 Lp(a) concentrations in NIDDM. Diabetes 1992 1.12
33 Myocardial infarction in Mexican-Americans and non-Hispanic whites. The San Antonio Heart Study. Circulation 1991 1.12
34 Predicting future cardiovascular disease: do we need the oral glucose tolerance test? Diabetes Care 2002 1.07
35 Nondiabetic Mexican-Americans do not have reduced insulin responses relative to nondiabetic non-Hispanic whites. Diabetes Care 1996 1.07
36 Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care 2004 1.07
37 Relationship of insulin clearance and secretion to insulin sensitivity in non-diabetic Mexican Americans. Eur J Clin Invest 1992 1.01
38 Level of control of hypertension in Mexican Americans and non-Hispanic whites. Hypertension 1993 0.99
39 Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes 1993 0.99
40 Central adiposity determines prevalence differences of the metabolic syndrome. Obes Res 2003 0.98
41 Leptin concentrations in relation to overall adiposity and regional body fat distribution in Mexican Americans. Int J Obes Relat Metab Disord 1996 0.97
42 Stability over time of modern diagnostic criteria for type II diabetes. Diabetes Care 1993 0.96
43 Prevalence of hypertension in Mexico City and San Antonio, Texas. Circulation 1994 0.95
44 Predicting diabetes. Moving beyond impaired glucose tolerance. Diabetes 1993 0.95
45 Was the historic contribution of Spain to the Mexican gene pool partially responsible for the higher prevalence of type 2 diabetes in mexican-origin populations? The Spanish Insulin Resistance Study Group, the San Antonio Heart Study, and the Mexico City Diabetes Study. Diabetes Care 2001 0.95
46 Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab 1994 0.94
47 Relationship of sex hormone-binding globulin to lipid, lipoprotein, glucose, and insulin concentrations in postmenopausal women. Metabolism 1992 0.94
48 Overweight and mortality in Mexican Americans. Int J Obes 1990 0.94
49 Lipoprotein(a) concentrations in Mexican Americans and non-Hispanic whites: the San Antonio Heart Study. Am J Epidemiol 1992 0.93
50 Leptin concentrations in diabetic and nondiabetic Mexican-Americans. Diabetes 1996 0.92
51 Ultrasonographically assessed maximum carotid artery wall thickness in Mexico City residents and Mexican Americans living in San Antonio, Texas. Association with diabetes and cardiovascular risk factors. Arterioscler Thromb Vasc Biol 1996 0.92
52 Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. Diabetologia 1997 0.91
53 Insulin secretion and resistance in nondiabetic Mexican Americans and non-Hispanic whites with a parental history of diabetes. J Clin Endocrinol Metab 1996 0.89
54 Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002 0.89
55 Sex difference in lifestyle factors predictive of diabetes in Mexican-Americans. Diabetes Care 1995 0.88
56 Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993 0.88
57 Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia 1993 0.86
58 Public health significance of upper body adiposity for non-insulin dependent diabetes mellitus in Mexican Americans. Int J Obes Relat Metab Disord 1992 0.85
59 Kelly West Lecture. Primary prevention of type II diabetes mellitus. Diabetes Care 1991 0.84
60 The influence of outpatient insurance coverage on the microvascular complications of non-insulin-dependent diabetes in Mexican Americans. J Diabetes Complications 1993 0.83
61 Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 1995 0.83
62 Are risk factors for conversion to NIDDM similar in high and low risk populations? Diabetologia 1997 0.83
63 Undiagnosed hypercholesterolemia: a serious health challenge. The Mexico City Diabetes Study. Arch Med Res 1996 0.81
64 Increased lipoprotein(a) concentrations in chronic renal failure. J Am Soc Nephrol 1992 0.81
65 A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 1995 0.81
66 Apolipoprotein E polymorphism and insulin levels in a biethnic population. Diabetes Care 1995 0.80
67 Plasma oxidizability in Mexican-Americans and non-Hispanic whites. Metabolism 1996 0.80
68 Insulin sensitivity and Lp(a) concentrations in normoglycemic men. Diabetes Care 1995 0.80
69 Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes. Metabolism 1992 0.80
70 Leptin concentrations are associated with higher proinsulin and insulin concentrations but a lower proinsulin/insulin ratio in non-diabetic subjects. Int J Obes Relat Metab Disord 1998 0.80
71 Myocardial infarction and cardiovascular risk factors in Mexico City and San Antonio, Texas. Arterioscler Thromb Vasc Biol 1995 0.79
72 Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb 1993 0.79
73 Rising trend in obesity in Mexican Americans and non-Hispanic whites: is it due to cigarette smoking cessation? Int J Obes Relat Metab Disord 2000 0.79
74 Apolipoprotein E polymorphism and LDL size in a biethnic population. Arterioscler Thromb Vasc Biol 1996 0.79
75 Does glycemic control of type II diabetes suffice to control diabetic dyslipidemia? A community perspective. Diabetes Care 1992 0.78
76 Differential impact of obesity in related populations. Obes Res 1995 0.78
77 Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas. Diabetes Care 1994 0.78
78 Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 1992 0.77
79 Lack of association between sex hormones and Lp(a) concentrations in American and Finnish men. Arterioscler Thromb 1994 0.77
80 Nephropathy in low income diabetics: the Mexico City Diabetes Study. Arch Med Res 1996 0.76
81 Higher proinsulin and specific insulin are both associated with a parental history of diabetes in nondiabetic Mexican-American subjects. Diabetes 1995 0.76
82 Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X"). Hypertension 1992 0.75
83 [Incidence and progression of diabetic retinopathy in low income population of Mexico City]. Rev Invest Clin 1999 0.75
84 Prevalence of hypertension in a Mexican population according to the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. J Cardiovasc Risk 1999 0.75
85 [Prevalence of diabetes and glucose intolerance in a urban population at a low economic level]. Rev Invest Clin 1993 0.75
86 LDL size and subclass pattern in Mexico City residents and San Antonio Mexican Americans. Arterioscler Thromb Vasc Biol 1995 0.75
Next 100